ArticleJournal of enzyme inhibition and medicinal chemistry2023

Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents.

Ahmed F Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.